Robert McDermott - ICoreConnect Common President CEO, Director

ICCT Stock  USD 0.17  0.01  5.56%   

CEO

Mr. Robert McDermott was appointed as President, Chief Executive Officer, Director of Imedicor, Inc., effective August 17, 2016. He was CEO of the Company since June 1, 2013. From April 2012 to June 2013, he was President of DoDilio LLC. Dodilio created a custom research exchange for Investors and Research Providers that allowed custom research to be purchased per the Investors specifications. While there he brought the company from prelaunch to exceeding that companys business plan. From 2010 through April of 2012, Mr. McDermott was President of Danwood America, a subsidiary of the Danwood Group of the United Kingdom. At Danwood America, he was accountable for all sales, customer satisfaction, new business, development of sales teams and defined business and marketing strategy. In 2010, Danwood America had acquired AXSA Document Solutions Inc., of Florida, a company that Mr. McDermott was a founder and was CEO for 15 years. AXSA, is a software and imaging company, and was acknowledged by INC 500 as one of Americas fastest growing companies. Mr. McDermott received degrees in Business Management and Finance from Dowling College in New York in 1994. since 2016.
Age 57
Tenure 8 years
Address 529 East Crown Point Road, Ocoee, FL, United States, 34761
Phone888 810 7706
Webhttps://www.icoreconnect.com

Robert McDermott Latest Insider Activity

Tracking and analyzing the buying and selling activities of Robert McDermott against ICoreConnect Common stock is an integral part of due diligence when investing in ICoreConnect Common. Robert McDermott insider activity provides valuable insight into whether ICoreConnect Common is net buyers or sellers over its current business cycle. Note, ICoreConnect Common insiders must abide by specific rules, including filing SEC forms every time they buy or sell ICoreConnect Common'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

ICoreConnect Common Management Efficiency

The company has return on total asset (ROA) of (0.6589) % which means that it has lost $0.6589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.4246) %, meaning that it created substantial loss on money invested by shareholders. ICoreConnect Common's management efficiency ratios could be used to measure how well ICoreConnect Common manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.58 in 2024. Return On Capital Employed is likely to gain to -1.43 in 2024. At this time, ICoreConnect Common's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 788.4 K in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.7 M in 2024.
iCoreConnect Common stock currently holds 7.88 M in liabilities. iCoreConnect Common stock has a current ratio of 0.34, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ICoreConnect Common's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

CEO Age

Timothy HannibalScworx Corp
56
Scott BoruffHealthcare Integrated Technolog
60
Dan McCarthyEvolent Health
39
Seth BlackleyEvolent Health
45
John RuizMSP Recovery
57
iCoreConnect Inc., a cloud-based software and technology company, provides cloud-based software products for the healthcare sector in the United States. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida. Vemics operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 55 people. iCoreConnect Common stock (ICCT) is traded on NASDAQ Exchange in USA. It is located in 529 East Crown Point Road, Ocoee, FL, United States, 34761 and employs 67 people. ICoreConnect Common is listed under Health Care Technology category by Fama And French industry classification.

Management Performance

iCoreConnect Common stock Leadership Team

Elected by the shareholders, the ICoreConnect Common's board of directors comprises two types of representatives: ICoreConnect Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ICoreConnect. The board's role is to monitor ICoreConnect Common's management team and ensure that shareholders' interests are well served. ICoreConnect Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ICoreConnect Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
Muralidar Chakravarthi, Chief Officer
David Fidanza, Chief Officer
Cile Spelce, Chief Officer
Michael Islek, Chief Advisor
Alyse Fidanza, Secretary
Stacey Trottier, Vice Sales
Archit Shah, Chief Officer
Robert McDermott, President CEO, Director
Chris Elley, Chief Officer
Jeffrey Stellinga, COO Director

ICoreConnect Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ICoreConnect Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ICoreConnect Stock Analysis

When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.